Effect of Dexmedetomidine on Nol-Index Guided Remifentanil Analgesia

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

April 11, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Nociceptive PainAnesthesiaOpioid UsePerioperative/Postoperative Complications
Interventions
DRUG

Dexmedetomidine

Patients in the dexmedetomidine-remifentanil group will receive an infusion of 0.6 mcg/kg in half an hour followed by an infusion of 0.6 mcg/kg/hour.

DRUG

sodium chloride

Patients in the remifentanil group will receive an infusion of 0.9% sodium chloride instead of dexmedetomidine (identical infusion rate)

DRUG

Remifentanil

Both groups will have remifentanil analgesia guided by the Nol-Index

Trial Locations (1)

1070

Erasme University Hospital, Brussels

All Listed Sponsors
collaborator

Saint-Pierre University Hospital

OTHER

lead

Erasme University Hospital

OTHER

NCT03912740 - Effect of Dexmedetomidine on Nol-Index Guided Remifentanil Analgesia | Biotech Hunter | Biotech Hunter